- Home
- GAMB vs RNAC Comparison
GAMB vs RNAC Comparison
Compare GAMB & RNAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GAMB | RNAC |
|---|---|---|
| Founded | 2006 | 2007 |
| Country | Jersey | United States |
| Employees | N/A | N/A |
| Industry | Services-Misc. Amusement & Recreation | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 167.7M | 163.3M |
| IPO Year | 2021 | 2016 |
Fundamental Metrics
Financial Performance| Metric | GAMB | RNAC |
|---|---|---|
| Price | $4.26 | $6.41 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 8 | 5 |
| Target Price | $9.79 | ★ $38.80 |
| AVG Volume (30 Days) | ★ 571.2K | 92.7K |
| Earning Date | 03-19-2026 | 03-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.05 | N/A |
| Revenue | ★ $154,519,000.00 | $1,091,000.00 |
| Revenue This Year | $32.40 | N/A |
| Revenue Next Year | $12.25 | N/A |
| P/E Ratio | $92.07 | ★ N/A |
| Revenue Growth | ★ 24.21 | N/A |
| 52 Week Low | $4.25 | $5.98 |
| 52 Week High | $17.14 | $20.00 |
Technical Indicators
Market Signals| Indicator | GAMB | RNAC |
|---|---|---|
| Relative Strength Index (RSI) | 29.67 | 37.62 |
| Support Level | $4.25 | $6.23 |
| Resistance Level | $4.74 | $6.60 |
| Average True Range (ATR) | 0.24 | 0.43 |
| MACD | -0.02 | -0.07 |
| Stochastic Oscillator | 7.27 | 16.02 |
Price Performance
Historical ComparisonAbout GAMB Gambling.com Group Limited
Gambling.com Group Ltd is a multi-award-winning performance marketing company and a provider of digital marketing services in the online gambling industry. Its principal focus is on online casinos online sports betting and the fantasy sports industry. It generates revenue by referring online gamblers to online gambling operators.
About RNAC Cartesian Therapeutics Inc.
Cartesian Therapeutics Inc is a clinical-stage biopharmaceutical company. The company uses its ImmTOR immune tolerance platform, which is designed to give rise to antigen-specific immunity, mitigating unwanted immune responses. The company leverages its proprietary technology and manufacturing platform to introduce one or more mRNA molecules into cells to enhance their function.